Navigation Links
WellPoint Reports Fourth Quarter and Full Year 2007 Results
Date:1/23/2008

ownturns. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. Except to the extent otherwise required by federal securities law, WellPoint does not undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Readers are also urged to carefully review and consider the various disclosures in WellPoint's SEC reports.


'/>"/>
SOURCE WellPoint, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine news :

1. WellPoint Announces Consumer Innovation Opportunity
2. WellPoint Appoints Brian A. Sassi as President and CEO of the Companys Consumer Business Unit
3. WellPoint Executive Mark Boxer Recognized as One of Computerworlds 2008 Premier 100 IT Leaders
4. WellPoint Announces Appointment of John Langenus as President of Anthem National Accounts
5. WellPoint Highlights 2007 Accomplishments and Strong 2008 Outlook at Annual Investor Meeting
6. WellPoint Announces Appointment of John Cannon III as Executive Vice President & General Counsel
7. WellPoint Provides Support and Resources to Most Vulnerable California Residents
8. WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors
9. WellPoint Reports Third Quarter 2007 Results
10. WellPoint NextRx Receives National Leadership Award for Innovative Web Tool
11. Wellpoint NextRx Receives TIPPS Certification from the HR Policy Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...pounds in cocoa could improve blood circulation, a...low// in menopausal women with high cholesterol.'T...es us new insights into how cocoa flavanols may im...sly known,' said Harold Schmitz, PhD, Chief Scienc...
... is a disease caused by filarial worm Onchocerca v...own as craw craw is an endemic disease in Bioko Is...y black flies causes weakening in affected individ...dividuals belong to labor force population it serv...
... labels to help cut heart disease, according to re...experts putting forward their arguments in this we...s vital in order to combat the UK's number one kil...ble for almost 50 per cent of deaths in Europe. I...
...ch activities under a common umbrella, Orchid Chem...out US-based Bexel Pharmaceuticals Inc by acquirin...hree million dollars). The company holds a majorit...d would acquire the remaining 26 per cent stake as...
Other Medicine News:Health News:River Blindness Incidence Reduced With Effective Treatment 2Health News:Scientists Push for Labeling of all Fats to Avoid Heart Disease 2
(Date:9/3/2008)...cuss Phase 3 Plans with FDA, PRINCETON, N.J., Sep...ounced today that it successfully completed two ke...y,s new, innovative low-dose, once-weekly,contrac...nternal product,code AG-200-15. The Phase 2b safet...endpoint of ovulation suppression, cycle control a...
(Date:9/3/2008)...s Strong Evidence Pycnogenol(R) Lowers Joint, Pain...Following Cessation of... -- According to the Center for,Disease Control (C...itis,is on the rise. A new study published in the...Pycnogenol(R), bark extract from the French mariti...
(Date:9/3/2008)...RNewswire-FirstCall/ -- A sub-analysis of,the TRIT...th prasugrel,compared with clopidogrel significant...cks (7.4 percent vs. 9.7 percent, p<0.0001), regar...me of an artery-opening,procedure known as percuta...rred spontaneously during the longer-term maintena...
(Date:9/2/2008)...ire-FirstCall/ --, - This Analysis Showed That Mu... by 34% in Patients With Atrial Fibrillation or At...ombotic Therapy, The results of a post-hoc analys...d today at the clinical trial update session of th... Munich, Germany. Previous results,from the landma...
Breaking Medicine Technology:Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 2Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 3Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 6Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers 24898 1LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers 24898 2LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers 24898 3Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008 2009 Season in the US 2766 1Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008 2009 Season in the US 2766 2Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008 2009 Season in the US 2766 3Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008 2009 Season in the US 2766 4Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008 2009 Season in the US 2766 5New HIV Infection Figures from CDC to be Announced on Aug 3 Underscore Need for National AIDS Strategy for the U S 24895 1New HIV Infection Figures from CDC to be Announced on Aug 3 Underscore Need for National AIDS Strategy for the U S 24895 2Anadys Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference 6896 1Anadys Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference 6896 2
...tations at American Association for Cancer Researc...7 /PRNewswire-FirstCall/ --,Medarex, Inc. today pr...- tumor activity from two separate studies explori...i-CD19 and anti-CD70,antibody-drug conjugates. CD1...body-drug conjugate approach to cancer therapy. Th...
... April 17, 2007 /PRNewswire/ -- Researchers from t...t, MI presented,strong evidence today that an anti...ts could be effective in eventually treating,certa... Prevention Program at Karmanos, and,members of hi...g,that the drug Clioquinol (CQ) appears to have an...
Other Medicine Technology:Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 2Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 3Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 4Alzheimer's Drug Shows Promise in Fighting Cancer 2
A convenient, rotating standholds up to seven Gilson pipettes (any model) with exceptional stability. Protects your precious pipettes from possible damage or contamination.
...eduling, performing and documenting gravimetric c...s and liquid handling devices. Collects weights d...c calibration protocols Meets ISO 8655, DIN 1265... setup information for balances Includes a datab...
...f solution ,• Individually wrapped or 5 pe...pour-out ,Disposable Multichannel Pipettor Solu...ttors. Angled sides and V-shaped bottom permits wi...orners have pouring lips to dispose of the excess ...
Reservoir, Low Profile, Single Well, Flat Bottom, 90mL Available Sterile
Medicine Products: